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While a number of transcription factors that are likely to play a role in cardiac differentiation have recently been described,
the signals that lead to the expression of these factors remains poorly understood. Here we report that exposure of Xenopus
embryos to continuous low levels of all-trans retinoic acid (RA), starting at the time of neural fold closure, blocks expression
of myocardial differentiation markers. The development of the remainder of the embryo is relatively normal, suggesting
that retinoic acid can act rather speci®cally on myocardial precursors. Indeed, the pattern of endocardial gene expression
appears to remain unaffected by RA treatment. Although RA blocks myocardial gene expression, a super®cially normal
heart tube forms. The heart tube, however, fails to loop during subsequent development and never forms beating tissue.
The effect of RA treatment on expression of myocardial genes is developmental stage dependent, since no in¯uence is
observed after myocardial differentiation has commenced. These data indicate that a vital component of the myocardial
determination pathway is sensitive to retinoid signaling. q 1997 Academic Press
INTRODUCTION et al., 1993; Tonissen et al., 1994; Evans et al., 1995), provid-
ing further evidence that the cardiogenic program is initi-
ated at this stage. Differentiation of the Xenopus heart be-A growing number of transcription factors that play a role
gins much later, at the tailbud stage (stage 26/27), basedin early cardiac development have been identi®ed. These
both on changes in morphology (Nieuwkoop and Faber,include homeobox-containing genes related to Drosophila
1994) and on the expression of cardiac-speci®c differentia-tinman (Lints et al., 1993; Tonissen et al., 1994; Schultheiss
tion products (Logan and Mohun, 1993; Drysdale et al.,et al., 1995; Evans et al., 1995; Lee et al., 1996), members
1994; Chambers et al., 1994).of the MADS box family (Edmondson et al., 1994), members
Sater and Jacobson (1990) have shown that, in Xenopus,of the GATA family (Kelley et al., 1993), and members of
the precardiac tissue has characteristics of an embryonicthe bHLH family (Srivastava et al., 1995). However, the
®eld, meaning that the area of tissue ®rst speci®ed to be-signaling processes that initiate the expression of these fac-
come heart is larger than the area that will differentiatetors remain unknown. In Xenopus, embryological studies
into heart. The process of generating a smaller heart-form-have determined that the heart precursor cells are speci®ed,
ing region does not appear to be due to migration of cardiacgaining the ability to express cardiac markers when cultured
precursors. Instead, a signal that inhibits the cardiogenicin a neutral environment, during gastrulation (Sater and
program at the periphery of the heart ®eld is likely to beJacobson, 1989; Nascone and Mercola, 1995). Expression of
responsible (Sater and Jacobson, 1990). The nature of thisseveral transcription factors known to be important for
signal remains unknown. This restriction of the ®eld mayheart development commences during gastrulation (Kelley
be related to the levels of the tinman-related genes Nkx2.5
and Nkx2.3. If the expression of these genes is elevated, a
larger number of cells express cardiac differentiation mark-1 To whom correspondence and reprint requests should be ad-
dressed. ers and a larger heart results. It seems likely that the ele-
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fertilization envelopes. Digoxygenin-labeled antisense RNA probesvated levels of these tinman-related proteins in the heart
for whole-mount in situ hybridization were synthesized according®eld act to resist the normal contraction of the heart ®eld
to Harland (1991) except that the probes were resuspended directly(Cleaver et al., 1996; Chen and Fishman, 1996).
in hybridization buffer without alkaline hydrolysis. The in situWe have identi®ed a simple treatment using retinoids
hybridization protocol of Harland (1991) was used with the follow-that causes a reduction in the expression of Nkx2.5 and
ing modi®cations. Tris-buffered saline (50 mM Tris, pH 7.4, 200
Nkx2.3 and blocks differentiation of the myocardium. The mM NaCl) was used throughout rather than phosphate-buffered
retinoid family of molecules acts on a variety of biological saline. Embryos were treated with 5 mg/ml proteinase K for 15 min.
functions through interactions with speci®c receptors and The 0.21 SSC washes were increased to 1 hr in length, the washes
binding proteins (reviewed in Giguere, 1994). Exposure to after the antibody incubation were increased in frequency, and the
total wash time was lengthened to 7 hr. RNase treatment used 1exogenous retinoids is teratogenic for a wide variety of
ml/ml of an RNase cocktail (Ambion). When the staining intensitystructures, and these structures appear to be most vulnera-
was suf®cient for viewing, the embryos were passaged through theble during the period of speci®cation (Shenefelt, 1972). In
following washes for 5 min each: 25% methanol, 50% methanol,response to RA treatment, changes in cell fate are often
75% methanol, 100% methanol, 75% methanol, 50% methanol,observed (Kessel and Gruss, 1991). More speci®cally, a num-
25% methanol. After the washes, the embryos were ®xed overnightber of studies have shown that heart development is sensi-
in Bouin's ®xative to give a yellow counterstain (Harland, 1991).
tive to exogenous retinoid treatment (Osmond et al., 1991; Embryos were cleared and photographed in 2 benzyl benzoate:1
Stainier and Fishman, 1992; Yutzey et al., 1994; Drysdale benzyl alcohol.
et al., 1994). Recently, heart defects have been observed in
mice lacking one or more speci®c retinoic acid receptors,
indicating that some aspect of RA signaling is required for Sectioning
normal heart development (Sucov et al., 1994; Kastner et
For serial sectioning, whole-mount stained embryos were rinsedal., 1994).
in PBS, dehydrated in ethanol (31 10 min), incubated in xylene (21In this paper, we demonstrate that exposure of Xenopus
10 min), in 1:1 xylene:paraplast (11 30 min), and then overnight
embryos to all-trans retinoic acid can completely block the in 100% paraplast, and embedded in paraplast. Sections (10 mm)
differentiation of the myocardium. The exposure to RA is were cut, mounted in Permount, and observed by differential inter-
initiated after the time of heart speci®cation and the effects ference optics.
are speci®c to the myocardiumÐthe endocardium is not
noticably affected. If, however, retinoic acid treatment is
Markersinitiated after myocardial differentiation has commenced,
there is no discernible effect on subsequent heart develop-
Complementary DNA clones encoding the following marker se-
ment. We conclude that the process of myocardial determi- quences were used as probes: neural-speci®c b-tubulin (Richter et
nation is sensitive to retinoic acid and that this treatment al., 1988), XNkx2.5 (Tonissen et al., 1994), cardiac Troponin I
may be mimicking a pathway that restricts the heart ®eld (XTnIc) (Drysdale et al., 1994), cardiac a-actin (Mohun et al., 1984),
during normal cardiogenesis. and X-msr (Devic et al., 1996Ðindependently isolated by M. Saha).
MATERIALS AND METHODS
RESULTSEmbryo Manipulations
Xenopus laevis embryos were generated as in Drysdale and Elin- Retinoic Acid Blocks the Expression of Myocardial
son (1991) except that adult females were not primed with pregnant Differentiation Markers
mare serum gonadotrophin. Embryos were dejellied in 2.5% cys-
teine, pH 8.0, and were staged according to Nieuwkoop and Faber Treatment of early stage Xenopus embryos with RA
(1994). causes severe axis defects and general loss of anterior struc-
Embryos were treated with various concentrations of all-trans tures (Durston et al., 1989; Sive et al., 1990; Drysdale and
retinoic acid (Sigma) in 20% Steinberg's medium. Dimethyl sulfox- Elinson, 1991). In order to focus on heart-speci®c effects of
ide was used as a carrier for the RA. Control embryos were im-
RA exposure we delayed the time of treatment until themersed in 1 ml/ml dimethyl sulfoxide (equivalent to the concentra-
midneurula stage. As shown in Fig. 1A, continuous expo-tion used for RA treatment) in 20% Steinberg's medium in the
sure to 1 mM RA, commencing at the midneurula stage,absence of RA.
results in a complete elimination of myocardial differentia-Embryos were dissected in full-strength NAM and the resulting
tion, as assayed using the myocardial marker XTnIc (Drys-embryos and explants were cultured in NAM/2. RA treatment of
explants was carried out as described for embryos above, except dale et al., 1994). To con®rm that the effect is not restricted
that the dishes were coated with 1% agar in NAM. to the XTnIc transcript alone, the assay was repeated using
probe for cardiac a-actin (Mohun et al., 1984). This marker
Whole-Mount in Situ Hybridization is expressed in somitic muscle, commencing at stage 14,
and also in cardiac muscle, starting at about stage 27 (Hem-Embryos and explants were ®xed for whole-mount in situ hybrid-
ization according to Harland (1991) after manual release from their mati-Brivanlou et al., 1990). As shown in Fig. 1B, no cardiac
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a-actin expression is detectable in the heart region of RA-
treated embryos, but expression in the somites appears to
be unaffected. In addition to these molecular markers, no
beating tissue is detectable when RA-treated embryos are
allowed to develop until the beating heart stage (after about
stage 34).
RA treatment of Xenopus embryos starting at the gastrula
stage causes severe reduction or ablation of the heart and
most other anterior structures, including anterior neural
tissues, cement gland, hatching gland, and eyes (Durston
et al., 1989; Sive et al., 1990; Drysdale and Elinson, 1991;
Drysdale and Crawford, 1994; Drysdale et al., 1994). In con-
trast, the later, low-dose treatment described above results
in very few defects in super®cial morphology. Minor de-
fects, however, are observed in the ventral part of the retina,
which does not differentiate normally, in the tail, which
does not fully elongate, and in gut morphogenesis. A similar
retinal defect has previously been reported in RA-treated
zebra®sh (Hyatt et al., 1996). To test for defects that might
not be visible at the super®cial level, neural tissues were
detected with probe for neural-speci®c b-tubulin (Richter
et al., 1988). As illustrated in Fig. 1C, neural structures in
RA-treated embryos appear normal, with the exception of
the trigeminal ganglion which is stunted compared to con-
trols. Note, however, that forebrain structures are present,
indicating that no signi®cant reduction of anterior neural
structures has occurred. As development proceeds, the ap-
pearance of the RA-treated embryos becomes more abnor-
mal and they begin to show severe edema, most likely due
to cardiac insuf®ciency.
Myocardial Development Is Sensitive to Retinoic
Acid until the Time of Differentiation
To determine the period during which myocardial differ-
entiation is sensitive to retinoid treatment, embryos were
incubated in RA, starting at progressively later times during
development. As shown in Fig. 2A, initiation of treatment
at any stage up until late neurula (stage 23) completely elim-
inates all detectable expression of myocardial markers. A
signi®cant reduction in the size of the myocardium is ob-
served when treatment is initiated at stage 25 (Fig. 2B).
However, when RA treatment is initiated at stage 28, just
after the onset of myocardial differentiation (Logan and Mo-
hun, 1993; Drysdale et al., 1994; Cleaver et al., 1996; Hem-
mati-Brivanlou et al., 1990), there is little or no detectable
alteration in heart development (Fig. 2C).
In this study, all embryos were assayed at the same devel-
opmental stage (stage 34), regardless of the time at which
RA-treatment commenced. It is possible therefore, that the
FIG. 1. RA treatment speci®cally blocks myocardial differentia-
tion in Xenopus embryos. Speci®c marker sequences have been
detected in control (top) and experimental embryos using whole- Detection of the a-cardiac actin sequence which is expressed in
both cardiac and somitic muscle in the early Xenopus embryo. (C)mount in situ hybridization. All embryos were assayed at stage 34.
(A) Detection of the myocardial-speci®c transcript XTnIc. (B) Detection of neural speci®c b-tubulin type II transcripts.
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extent of myocardial marker expression depends on the to-
tal time that the developing myocardium is exposed to RA,
rather than to the developmental stage at which the treat-
ment is initiated. To test this possibility, embryos were
exposed to constant 1 mM RA, starting at stage 28, and
allowed to develop for several days. These embryos devel-
oped hearts of normal size and morphology, indicating that
the stage at which treatment is initiated, rather than the
duration, determines the extent of myocardial loss (data not
shown).
The Pattern of XNkx-2.5 Expression Is Altered by
Retinoic Acid
The homeobox sequence Nkx2.5 (XNkx2.5 in Xenopus)
is expressed in cardiac progenitors and the adjacent pharyn-
geal region in the early embryo (Lints et al., 1993; Tonissen
et al., 1994; Schultheiss et al., 1995; Lee et al., 1996). In the
Xenopus embryo, XNkx2.5 expression commences during
gastrulation (stage 11±12) (Tonissen et al., 1994), the time
that the heart is thought to be speci®ed (Sater and Jacobson,
1989; Nascone and Mercola, 1995). Gene ablation studies in
mouse indicate that Nkx2.5 is essential for normal cardiac
morphogenesis (Lyons et al., 1995) and over-expression ex-
periments in the frog suggest that XNkx2.5 normally func-
tions to maintain precardiac mesoderm in a state competent
to respond to additional cardiac differentiation signals
(Cleaver et al., 1996). The peak of XNkx2.5 expression in
the Xenopus embryo occurs at the tailbud stage (Tonissen
et al., 1994; Evans et al., 1995) about 8 hr before the onset
of cardiac differentiation. To determine whether XNkx2.5
expression is susceptible to RA, embryos were exposed to
continuous RA starting at stage 20/21 and then assayed by
in situ hybridization at various later stages of development.
It is important to emphasize that stage 20 is well after the
onset of XNkx2.5 expression. As shown in Fig. 3A, embryos
assayed at stage 24, only about 5 hr after initiation of RA
treatment, showed greatly reduced expression of XNkx2.5.
This decrease in expression is most pronounced in the pre-
cardiac region. In stage 32 embryos, where the heart tube
is forming, XNkx2.5 transcripts remain visible in the pha-
ryngeal region, but are undetectable in myocardial cells
(Figs. 3B and 3C). As the RA treatment was initiated at the
time XNkx2.5 expression is at its peak in the embryo, the
rapid decline in XNkx-2.5 transcripts suggests that the
mRNA has a rather short half-life and that RA treatment
effectively blocks expression of the XNkx2.5 gene in cardiac
precursor cells. A second tinman-related homeobox gene,
cardial-speci®c marker sequence, XTnIc, in control (top) and experi-
mental embryos. All embryos are assayed at stage 34. (A) Continu-
ous treatment with 1 mM RA initiated at stage 23. (B) ContinuousFIG. 2. Myocardial development is sensitive to RA-treatment up
until the time that myocardial marker sequences are expressed. treatment with 1 mM RA initiated at stage 25. (C) Continuous
treatment with 1 mM RA initiated at stage 28.Whole-mount in situ hybridization assay for expression of the myo-
Copyright q 1997 by Academic Press. All rights of reproduction in any form reserved.
AID DB 8623 / 6x28$$$141 07-23-97 21:54:23 dbas
209RA Blocks Myocardial Differentiation
XNkx2.3, has an expression pattern almost identical to
XNkx2.5 in the Xenopus embryo (Evans et al., 1995; Cleaver
et al., 1996) and has the same biological properties when
over-expressed in the embryo (Cleaver et al., 1996). In situ
hybridization experiments indicate that the pro®le of
XNkx2.3 expression is the same as XNkx2.5 in embryos
treated with RA (data not shown).
Limited Cardiac Morphogenesis Occurs in the
Absence of Myocardial-Speci®c Gene Expression
To determine the fate of the presumptive myocardial cells
in RA-treated embryos, tissue sections were examined after
the time of cardiac differentiation. Control and RA-treated
embryos assayed for expression of the myocardial-speci®c
marker, XTnIc, are shown in Figs. 4A and 4B, respectively.
The control embryo shows a region of intense XTnIc stain-
ing, restricted to the myocardial layer. The myocardial tis-
sue has delaminated from the epithelial layer of cells and
clearly encloses a region of unstained endocardial tissue. In
comparison, the presumptive myocardial layer in the RA-
treated embryo shows the same delaminated appearance,
but is completely devoid of XTnIc expression.
The presence of endocardial tissue in the hearts of RA-
treated embryos was assayed using the endothelial marker
sequence, X-msr (Devic et al., 1996). X-msr encodes a G
protein-coupled receptor that is related to, but distinct from,
the angiotensin II receptor, and which is expressed in devel-
oping endothelial tissues including the endocardium (Devic
et al., 1996). Control and RA-treated embryos at stage 32
were assayed for X-msr sequences by whole-mount in situ
hybridization are shown in Figs. 4C and 4D, respectively.
The endocardial layer in the control embryo is visible as
a thin tubular structure, continuous with the developing
vascular system and the appearance in RA-treated embryos
is similar, although the developing vasculature of the head
appears somewhat disorganized. Figures 4E and 4F show
histological sections through the heart region of control and
RA-treated embryos, respectively, assayed for X-msr se-
quences. The presence of a distinct group of endocardial
cells in both control and RA-treated embryos demonstrates
that endocardial development is largely resistant to RA
treatment that eliminates detectable expression of myocar-
dial markers.
Figure 4G shows the endocardium in sections through a
stage 35 control embryo, after the heart tube has folded.
The stained endocardial layer is separated from a thin-
walled and extensively folded myocardial layer. By compari-
son, the endocardial layer in the RA-treated embryo (Fig.
FIG. 3. Expression of the tinman-related homeodomain sequence, 4H) is located in close contact to a thick-walled and un-
XNkx-2.5 in RA-treated embryos. XNkx-2.5 sequences were de-
tected by whole-mount in situ hybridization. (A) RA treatment
was initiated at stage 20/21 and embryos were assayed at stage 24.
Control embryo is on the left. Note the loss of Nkx-2.5 expression
from the cardiac precursor region but not from the pharyngeal re- pharyngeal region (ph) are indicated. (C) RA-treated embryo assayed
at stage 32. Note that XNkx-2.5 transcripts are detected in thegion. (B) Control embryo assayed at stage 32, after the onset of
myocardial marker expression. The folding heart tube (ht) and the pharyngeal region (ph) but not in the region of the heart tube (ht).
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folded layer of tissue. This tissue layer would normally have sion of myocardial differentiation markers has commenced,
formed differentiated myocardium. In the normal heart, the RA has no discernible effect on the myocardium. Although
endocardium is separated from the myocardium by a layer previous studies have shown that exposure of gastrula stage
of extracellular matrix material (the cardiac jelly) (reviewed embryos to RA causes loss of the myocardium (Sive et al.,
in Borg et al., 1995). The immediate juxtaposition of the 1990), these embryos suffered severe truncations of all
endocardium and the myocardial layers in the RA-treated dorso-anterior structures (Durston et al., 1989). Under these
embryos suggests that the extracellular matrix has failed to conditions, loss of the heart is likely to be a secondary effect,
form and that a differentiated myocardium may be neces- resulting from loss of other dorso-anterior structures that
sary for cardiac jelly formation. are required to specify the myocardium. This possibility is
supported by experiments which demonstrate that a heart-
inducing signal emanates from dorso-anterior structures atRetinoic Acid Can Block Myocardial
the time of gastrulation (Sater and Jacobson, 1989; NasconeDifferentiation in Explants of Cardiac Progenitors
and Mercola, 1995; Antin et al., 1994).
Although embryos appear relatively normal after RA When embryos are treated with RA during neurula stages
treatment, some axial defects are observed (Fig. 1). This (Fig. 1), it is unlikely that the loss of myocardium is a sec-
raises the possibility that RA affects myocardial differentia- ondary effect, resulting from the in¯uence of RA on another
tion by causing defects in other tissues that subsequently tissue. First, the paucity of general embryonic defects sug-
result in a block to myocardial differentiation. To test this gests that most tissues are developing normally. Second,
possibility, the cardiac progenitor region, as deduced by no additional signals or trophic factors are necessary for
XNkx2.5 expression (Tonissen et al., 1994), was explanted formation of a functional heart in Xenopus after gastrula-
at stage 20/21 and cultured in the presence of 1 mM RA. tion (Sater and Jacobson, 1989; Nascone and Mercola, 1995).
Control explants normally give rise to a differentiated heart Third, explants of the presumptive myocardium taken at
and immediately adjacent tissues (Fig. 5C), but in the pres- neurula stages (20/21), and cultured in the presence of RA,
ence of RA no cardiac troponin I expression is detected in fail to form a myocardium (Fig. 5).
the explants (Fig. 5D). Since these explants inevitably con- Our results strongly suggest that exogenous RA blocks
tain some other tissue in addition to heart, we cannot com- expression of myocardial differentiation markers in general,
pletely exclude the possibility that RA is blocking myocar- and not just the expression of a subset of myocardial genes.
dial differentiation by altering another tissue; however, our This is most clearly demonstrated by expression of the car-
results indicate that the majority of tissues in the embryo diac a-actin gene, which is completely absent in the cardiac
are not involved (see Fig. 5B). region of the embryo, but remains at normal levels in the
somites (Fig. 1). In addition, late stage embryos fail to ex-
hibit any detectable heart beat, indicating a failure to form
DISCUSSION the contractile apparatus. On the other hand, expression of
endocardial genes and formation of the simple heart tube
Retinoic Acid Can Block Myocardial appears to proceed normally in the presence of RA. The
Differentiation in a Stage-Speci®c Manner fusion of the two heart primordia has already been initiated
at the time RA is added (Nieuwkoop and Faber, 1994), and,We have demonstrated that exogenous RA can com-
at later stages, a morphologically normal tube is present atpletely block the differentiation of the myocardium when
the position of the myocardium (Figs. 4G and 4H). Overall,applied at a relatively late stage in the cardiogenic program.
these observations suggest that the primary defect lies inThe window of RA sensitivity extends until the tailbud
stage when myocardial differentiation occurs. Once expres- the differentiation of the myocardium and does not result
FIG. 4. RA treatment blocks expression of myocardial but not endocardial marker transcripts. Expression of the myocardial-speci®c
sequence, XTnIc, or the endothelial marker sequence, X-msr, was detected by whole-mount in situ hybridization. (A) Transverse section
through the heart region of a stage 32 embryo, stained for XTnIc expression. (B) Transverse section through the heart region of an RA-
treated embryo stained for XTnIc transcripts. Although tissue layers similar to those in the control embryo are present, there is no
detectable expression of XTnIc. (C) Stage 32 control embryo stained for the endothelial marker X-msr. The position of the endocardium
(ec) is indicated. (D) RA-treated embryo assayed at stage 32 for the endothelial marker, X-msr. The position of the endocardium (ec) is
indicated. (E) Transverse section through the heart region of a stage 32 control embryo stained for X-msr. (F) Transverse section through
the heart region of a stage 32 RA-treated embryo, stained for X-msr. Note the presence of the endocardial tissue in both control and RA-
treated embryos. (G) Transverse section through the heart region of a stage 35 control embryo stained for X-msr sequences. Note the
separation of the endocardial tissue layer from the highly folded myocardial layer. (H) Transverse section through the heart region of a
stage 35, RA-treated embryo, stained for X-msr sequences. The stained endocardial cells are located adjacent to the thick layer of unfolded
tissue which occupies the position of the heart tube.
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FIG. 5. RA treatment of heart region explants. Explants of the presumptive cardiac region were taken from normal embryos at stage 20/
21 and cultured until stage 33/34, well after the time of cardiac differentiation. In all panels, differentiated myocardial tissue is detected
by whole-mount in situ hybridization to XTnIc transcripts. The fate of the explanted region can be seen by comparing a normal embryo
(A), to a similar embryo from which the presumptive cardiac region has been removed (B). Control explants differentiate to form cardiac
tissue (C), while explants incubated in 1 mM RA exhibit no detectable cardiac troponin I expression (D).
from the elimination of presumptive myocardial cells. We normally act to block precocious differentiation of the myo-
cardium (Kastner et al., 1995), raising the possibility thatare not aware of any other example where limited morpho-
exogenous RA may be acting on such a function. Blockinggenesis occurs in the absence of overt differentiation.
retinoid signaling by dietary insuf®ciency of vitamin A or
by addition of anti-RA antibodies also results in cardiac
defects (Twal et al., 1995). Although the mechanism re-How Is Retinoic Acid Exerting Its Effect?
mains unknown, addition of excess RA often results in sim-
It is clear that retinoids play a role in normal heart devel- ilar defects to those observed when RA signaling is dis-
opment. Mice lacking function of speci®c retinoid recep- rupted (Means and Gudas, 1995). While addition of exoge-
tors, or combinations of these receptors, often have defects nous RA is known to in¯uence heart development in other
in cardiac development (Sucov et al., 1994; Kastner et al., species (Osmond et al., 1991; Stainier and Fishman, 1992;
1995) although in all cases myocardial differentiation mark- Yutzey et al., 1994), the observed effects do not include loss
ers are expressed. It should be noted that a possible explana- of myocardial gene expression. The increased sensitivity
of the developing Xenopus myocardium may result from ation of the RXRa knockout phenotype is that RXRa may
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greater effective dose of RA, because the embryos are im- spond to a reduction in the XNkx2.5/XNkx2.3 expression
domain and we have found that the level of both XNkx2.5mersed in a solution of RA. This is consistent with the
observation that neural defects resulting from RA exposure and XNkx2.3 transcripts decline rapidly after RA treat-
ment. However, it is unlikely that RA is the normal me-are also more pronounced in Xenopus (Durston et al., 1989)
when compared to mammalian embryos (Morriss-Kay et al., diatior of heart ®eld contraction. While targeted disrup-
tion of retinoic acid receptors has a marked effect on1991; Conlon and Rossant, 1992).
The RA signaling pathway is capable of regulating gene cardiac development, enlarged hearts are never observed
(Sucov et al., 1994; Kastner et al., 1995). An increase inexpression (Giguerre, 1994) and it is possible that exogenous
RA alters the expression of a gene required for myocardial heart size might be expected if retinoic acid is normally
responsible for reduction in the heart ®eld. It is plausible,differentiation. One potential target of RA regulation is the
homeodomain gene Nkx2.5 (Lints et al., 1993; Komura and however, that understanding the mechanism by which
RA has its striking effect on myocardial differentiation,Izumo, 1993; Tonissen et al., 1994), which is expressed at
high levels in the developing heart and which is required will provide clues to the normal processes underlying
heart ®eld contraction.for correct heart development (Lyons et al., 1995). We have
shown that RA treatment rapidly reduces levels of XNkx2.5
transcript in the presumptive cardiac region (Fig. 3). When
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